Aspen Aerogels (NYSE:ASPN) Raised to "Sell" at StockNews.com

StockNews.com upgraded shares of Aspen Aerogels (NYSE:ASPN - Free Report) to a sell rating in a research report sent to investors on Wednesday morning.

Several other equities research analysts also recently issued reports on ASPN. Craig Hallum dropped their price target on shares of Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating on the stock in a research note on Friday, February 14th. Piper Sandler dropped their price target on shares of Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating on the stock in a research note on Tuesday, October 22nd. Seaport Res Ptn lowered shares of Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 12th. Canaccord Genuity Group decreased their price objective on shares of Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating for the company in a report on Friday, February 14th. Finally, Roth Mkm decreased their price objective on shares of Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating for the company in a report on Friday, February 14th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $22.44.

Aspen Aerogels Trading Down 1.4 %

Shares of ASPN stock traded down $0.12 during mid-day trading on Wednesday, reaching $8.04. The company's stock had a trading volume of 2,204,052 shares, compared to its average volume of 2,149,168. The company's 50 day simple moving average is $11.75 and its 200-day simple moving average is $18.15. Aspen Aerogels has a 12-month low of $7.96 and a 12-month high of $33.15. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The firm has a market capitalization of $659.27 million, a PE ratio of 50.22 and a beta of 2.14.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, beating analysts' consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. On average, research analysts predict that Aspen Aerogels will post 0.22 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the business. Toronto Dominion Bank acquired a new position in shares of Aspen Aerogels in the 4th quarter valued at about $266,000. AWM Investment Company Inc. boosted its holdings in shares of Aspen Aerogels by 2.9% in the 4th quarter. AWM Investment Company Inc. now owns 1,208,686 shares of the construction company's stock valued at $14,359,000 after buying an additional 34,115 shares during the period. Connective Capital Management LLC acquired a new position in shares of Aspen Aerogels in the 4th quarter valued at about $433,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Aspen Aerogels by 47.3% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 588,395 shares of the construction company's stock valued at $6,990,000 after buying an additional 188,861 shares during the period. Finally, Voloridge Investment Management LLC bought a new stake in Aspen Aerogels in the 4th quarter valued at about $3,089,000. 97.64% of the stock is owned by institutional investors and hedge funds.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.